The anti-VEGF antibody bevacizumab potently reduces the growth rate of high-risk neuroblastoma xenografts (Q40229319)
Jump to navigation
Jump to search
scientific article published on 20 September 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The anti-VEGF antibody bevacizumab potently reduces the growth rate of high-risk neuroblastoma xenografts |
scientific article published on 20 September 2006 |
Statements
1 reference
The anti-VEGF antibody bevacizumab potently reduces the growth rate of high-risk neuroblastoma xenografts (English)
1 reference
Lova Segerström
1 reference
Dieter Fuchs
1 reference
Ulrika Bäckman
1 reference
Kajsa Holmquist
1 reference
Rolf Christofferson
1 reference
Faranak Azarbayjani
1 reference
20 September 2006
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference